General introduction
Our mission
To cure every child with cancer, with optimal quality of life.
When a child is seriously ill from cancer, only one thing matters: a cure. Every year, 600 children in the Netherlands are diagnosed with cancer. Sadly, one in four of these children dies. That is why in the Princess Máxima Center for pediatric oncology, we work together with passion and without limits every day to improve the survival rate and quality of life of children with cancer. Now, and in the long term. Because children have their whole lives ahead of them.
Strategic goals
Focused and promising
The Princess Máxima Center works with ‘Focused and promising’, our strategy for 2020-2024. With this, we aim to achieve results that contribute to our mission to cure every child with cancer, with optimal quality of life. Through six key objectives, the Princess Máxima Center expresses its clear commitment to new developments that we currently consider the most promising in terms of realizing our mission.
Facts & Figures 2022
General facts & figures
Education in figures
Healthcare professionals in training
Educational moments
Interns
Care in figures
Nursing days
Number of new patients in 2022
Number of clinical admissions
Outpatient visits
Patient satisfaction score
8,9
Number of day treatments
Average bed occupation
Number of surgeries
Average duration of stay (days)
7.5
Research in figures
Research groups
Core facilities
Open clinical studies
Publications
PhD students
Professors
New patient numbers
based on Dutch Childhood Oncology Group date of diagnosis
Total new diagnoses: 576 Total relapses: 163 Suspected malignant tumors (extensive diagnostics): 163 Total: 902 * including 14 late new diagnoses or relapses from 2021
Total new diagnoses: 576
Total relapses: 163
Suspected malignant tumors (extensive diagnostics): 163
Total: 902
* including 14 late new diagnoses or relapses from 2021
Spread of new patients in 2022
According to ICCC-3 classification
Spread of new patients in 2022
According to ICCC-3 classification
1. Lymphoid leukemias (107) 2. Acute myeloid leukemias (28) 3. Chronic myeloproliferative diseases (6) 4. Myelodysplastic syndrome and other myeloproliferative diseases (5) 5. Unspecified and other specified leukemias (3) 6. Lymphomas and reticuloendothelial neoplasms (83) 7. Non ICCC-3: Haemophagocytic lymphohistiocytosis (HLH) (2) 8. Non ICCC-3: Neoplasm of histiocytes and accesory lymphoid cells (14) 9. Non ICCC-3: Fanconi or (Severe) Aplastic - Anaemia (8) 10. Ependymomas and choroid plexus tumor (6) 11. Astrocytomas (89) 12. Intracranial and intraspinal embryonal tumors (20) 13. Other specified intracranial and intraspinal neoplasms (13) 14. Intracranial and intraspinal germ cell tumors (4) 15. Neuroblastoma and ganglioneuroblastoma (24) 16. Renal tumors (33) 17. Hepatoblastoma (3) 18. Osteosarcomas (14) 19. Ewing sarcoma and other bone sarcomas (16) 20. Rhabdomyosarcomas (17) 21. Fibrosarcomas, peripheral nerve sheath tumors, and other fibrous neoplasms (25) 22. Malignant extracranial and extragonadal germ cell tumors (30) 23. Nasopharyngeal carcinomas (1) 24. Other and unspecified carcinomas (25)